Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 80,000,000
- Total 13F shares
- 48,677,430
- Share change
- -629,880
- Total reported value
- $2,169,609,749
- Put/Call ratio
- 37%
- Reported price per share
- $44.57
- Number of holders
- 163
- Value change
- -$9,316,822
- Number of buys
- 78
- Number of sells
- 71
Security identity
Holder snapshot
Report period
Q4 2022
Institutions
163
Top holders
10
CLDX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117B202
Recent filing periods:
Ownership snapshot
Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FMR LLC
13D/G signal
—
Evidence rows
15
Latest as of
30 Sep 2022
13F
Lead comparable stake: 8.8%
Showing 1-6 of 15 holder rows.
Rank 1 holder
FMR LLC
13F
- Ownership
- 8.8%
- Position
- $197.22M
Rank 2 holder
STATE STREET CORP
13F
- Ownership
- 4%
- Position
- $89.15M
Rank 3 holder
BlackRock Finance, Inc.
13F
- Ownership
- 3.9%
- Position
- $88M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
8.8%
|
$197,215,000
7,015,843 shares
|
— | 30 Sep 2022 |
| STATE STREET CORP |
13F
Company
|
4%
|
$89,153,000
3,171,578 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
3.9%
|
$87,995,000
3,130,413 shares
|
— | 30 Sep 2022 |
| RTW INVESTMENTS, LP |
13F
Company
|
3.9%
|
$86,697,000
3,084,215 shares
|
— | 30 Sep 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
3.9%
|
$86,600,000
3,080,733 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
3.1%
|
$69,583,000
2,475,381 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
163
Shares
48,677,430
Rows available
163
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
146
Q4 2022 holders
163
Holder diff
17
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend